Cargando…
Advances in Lung Cancer Treatment Using Nanomedicines
[Image: see text] Carcinoma of the lungs is among the most menacing forms of malignancy and has a poor prognosis, with a low overall survival rate due to delayed detection and ineffectiveness of conventional therapy. Therefore, drug delivery strategies that may overcome undesired damage to healthy c...
Autores principales: | Sharma, Akshansh, Shambhwani, Devanshi, Pandey, Sadanand, Singh, Jay, Lalhlenmawia, Hauzel, Kumarasamy, Murali, Singh, Sachin Kumar, Chellappan, Dinesh Kumar, Gupta, Gaurav, Prasher, Parteek, Dua, Kamal, Kumar, Deepak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835549/ https://www.ncbi.nlm.nih.gov/pubmed/36643475 http://dx.doi.org/10.1021/acsomega.2c04078 |
Ejemplares similares
-
Emerging prospects of vitamin D3 in metabolic syndrome: A proof of concept (POC) approach targeting inflammation
por: Singh, Yogendra, et al.
Publicado: (2020) -
Adenocarcinoma - success so far and the way ahead
por: Fatima, Rabab, et al.
Publicado: (2023) -
Luteolin: a flavonoid with a multifaceted anticancer potential
por: Prasher, Parteek, et al.
Publicado: (2022) -
Vesicular drug-delivery systems as theranostics in COVID-19
por: Satija, Saurabh, et al.
Publicado: (2020) -
A novel nano therapeutic using convalescent plasma derived exosomal (CP(Exo)) for COVID-19: A combined hyperactive immune modulation and diagnostics
por: Anand, Krishnan, et al.
Publicado: (2021)